{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:36:01Z","timestamp":1784867761205,"version":"3.55.0"},"reference-count":16,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2015,10,19]]},"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Children needing intravenous antibiotics for cellulitis are usually admitted to hospital, whereas adults commonly receive intravenous treatment at home. This is a randomised controlled trial (RCT) of intravenous antibiotic treatment of cellulitis in children comparing administration of ceftriaxone at home with standard care of flucloxacillin in hospital. The study aims to compare (1) the rate of treatment failure at home versus hospital (2) the safety of treatment at home versus hospital; and (3) the effect of exposure to short course ceftriaxone versus flucloxacillin on nasal and gut micro-organism resistance patterns and the clinical implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      Inclusion criteria: children aged 6\u2005months to &lt;18\u2005years with uncomplicated moderate\/severe cellulitis, requiring intravenous antibiotics. Exclusions: complicated cellulitis (eg, orbital, foreign body) and immunosuppressed or toxic patients. The study is a single-centre, open-label, non-inferiority RCT. It is set in the emergency department (ED) at the Royal Children's Hospital (RCH) in Melbourne, Australia and the Hospital-in-the-Home (HITH) programme; a home-care programme, which provides outreach from RCH. Recruitment will occur in ED from January 2015 to December 2016. Participants will be randomised to either treatment in hospital, or transfer home under the HITH programme. The calculated sample size is 188 patients (94 per group) and data will be analysed by intention-to-treat.\n                      <jats:italic>Primary outcome<\/jats:italic>\n                      : treatment failure defined as a change in treatment due to lack of clinical improvement according to the treating physician or adverse events, within 48\u2005h\n                      <jats:italic>Secondary outcomes<\/jats:italic>\n                      : readmission to hospital, representation, adverse events, length of stay, microbiological results, development of resistance, cost-effectiveness, patient\/parent satisfaction. This study has started recruitment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      This study has been approved by the Human Research Ethics Committee of the RCH Melbourne (34254C) and registered with the ClinicalTrials.gov registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02334124\">NCT02334124<\/jats:ext-link>\n                      ). We aim to disseminate the findings through international peer-reviewed journals and conferences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial<\/jats:title>\n                    <jats:p>Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2015-009606","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T22:48:36Z","timestamp":1452552516000},"page":"e009606","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Cellulitis: Home Or Inpatient in Children from the Emergency Department (CHOICE): protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"6","clinical-trial-number":[{"clinical-trial-number":"nct02334124","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Laila F","family":"Ibrahim","sequence":"first","affiliation":[{"name":"RCH@Home Department, The Royal Children's Hospital, Parkville, Victoria, Australia"},{"name":"Murdoch Children's Research Institute, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz E","family":"Babl","sequence":"additional","affiliation":[{"name":"Murdoch Children's Research Institute, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Emergency Department, The Royal Children's Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Orsini","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy M","family":"Hopper","sequence":"additional","affiliation":[{"name":"Murdoch Children's Research Institute, Parkville, Victoria, Australia"},{"name":"Emergency Department, The Royal Children's Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope A","family":"Bryant","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital, Parkville, Victoria, Australia"},{"name":"RCH@Home Department, The Royal Children's Hospital, Parkville, Victoria, Australia"},{"name":"Murdoch Children's Research Institute, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"2025121400520888000_6.1.e009606.1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/TP.0b013e31816a3267","article-title":"Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition","volume":"85","author":"Svahn","year":"2008","journal-title":"Transplantation"},{"key":"2025121400520888000_6.1.e009606.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2214.2005.00550.x"},{"key":"2025121400520888000_6.1.e009606.3","doi-asserted-by":"crossref","unstructured":"Balaguer A , Gonzalez de Dios J . Home versus hospital intravenous antibiotic therapy for cystic fibrosis. Cochrane Database Syst Rev 2012;(3):CD001917. doi:10.1002\/14651858.CD001917.pub3","DOI":"10.1002\/14651858.CD001917.pub3"},{"key":"2025121400520888000_6.1.e009606.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2007.01236.x"},{"key":"2025121400520888000_6.1.e009606.5","doi-asserted-by":"crossref","unstructured":"Ibrahim LF , Hopper SM , Babl FE , et al . Who can safely have antibiotics at home? A prospective observational study in children with moderate\/severe cellulitis. Pediatr Infect Dis J 13 Nov 2015. [Epub ahead of print] www.ncbi.nlm.nih.gov\/pubmed\/26569189 doi:10.1097\/INF.0000000000000992","DOI":"10.1097\/INF.0000000000000992"},{"key":"2025121400520888000_6.1.e009606.6","doi-asserted-by":"publisher","DOI":"10.1086\/497143"},{"key":"2025121400520888000_6.1.e009606.7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00006454-198501000-00008","article-title":"Ceftriaxone in the treatment of infections caused by Staphylococcus aureus in children","volume":"4","author":"Nelson","year":"1985","journal-title":"Pediatr Infect Dis"},{"issue":"(3 Pt 2)","key":"2025121400520888000_6.1.e009606.8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1542\/peds.82.3.486","article-title":"Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children","volume":"82","author":"Frenkel","year":"1988","journal-title":"Pediatrics"},{"key":"2025121400520888000_6.1.e009606.9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00006454-198909000-00008","article-title":"Randomized comparative study of ampicillin\/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children","volume":"8","author":"Kulhanjian","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"2025121400520888000_6.1.e009606.10","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e318248b19b"},{"key":"2025121400520888000_6.1.e009606.11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00044011-199612050-00001","article-title":"A randomised comparative study of once-daily ceftriaxone and 6-hourly flucloxacillin in the treatment of moderate to severe cellulitis\u2014Clinical efficacy, safety and pharmacoeconomic implications","volume":"12","author":"Vinen","year":"1996","journal-title":"Clin Drug Investig"},{"key":"2025121400520888000_6.1.e009606.12","unstructured":"Ibrahim LF , Hopper SM , Sacks B , et al . Pilot study of the safety and acceptability of parenteral antibiotics in children referred from the Emergency Department directly to Hospital-In-The-Home. The 8th World Congress of the World Society for Pediatric Infectious Disease (WSPID 2013) ; Cape Town, South Africa, 2013."},{"key":"2025121400520888000_6.1.e009606.13","unstructured":"Ibrahim LF , Hopper SM , Babl FE , et al . A comparison of treatment at home or in hospital for moderate\/severe cellulitis in children. Australasian Society for Infectious Diseases Annual Scientific Meeting ; Adelaide, Australia, 2014."},{"key":"2025121400520888000_6.1.e009606.14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2443"},{"key":"2025121400520888000_6.1.e009606.15","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/pbc.25012","article-title":"Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial","volume":"61","author":"Orme","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2025121400520888000_6.1.e009606.16","unstructured":"Ibrahim LF , Hopper SM , Babl FE , et al . The CHOICE study: Cellulitis treatment at Home Or Inpatient in Children from Emergency. Australasian College for Emergency Medicine Annual Scientific Meeting ; Melbourne, Australia, 2014."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2015-009606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:52:21Z","timestamp":1765702341000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2015-009606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,11]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/bmjopen-2015-009606"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2015-009606","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}